[Goal: a long-term successful HIV therapy. Nevirapine as sustained-release tablet offers good prospects].
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008134:Long-Term Care; D055118:Medication Adherence; D019829:Nevirapine / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D019380:Anti-HIV Agents; D003692:Delayed-Action Preparations; D019829:Nevirapine